Caplight Logo









Exo

Exo

Private
Santa Clara, CaliforniaHealthcare & Life Scienceshttps://www.exo.inc

Last Round

Strategic

May 28, 2025

Total Funding Raised

$322.33M

Company Overview

Exo (Diagnostic Equipment) is a medical technology company that develops a handheld ultrasound device designed to enhance medical imaging and therapeutic applications for healthcare professionals, allowing for critical real-time decision-making that improves patient outcomes at a lower and more convenient cost.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical Devices, Medical AI, Workflow Automation

Business Model

B2B

Customer Profile

Hardware + Subscription, Subscription SaaS, Hardware Sales, Freemium

AI Layer

Application

Keywords

handheld ultrasoundpoint-of-care ultrasoundPOCUSmedical imaging AIPOCUS workflow softwareportable ultrasoundpocket ultrasoundmedical imaging platformAI-assisted diagnosticspMUT technologyFDA-cleared AIEHR integrationPOCUS billingultrasound transducer techhealthcare SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Exo Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Exo Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
StrategicMay 28, 2025
DebtAug 2, 2024
Series CJul 29, 2021
Series B ExtensionAug 20, 2020
Series BAug 5, 2019
Series A
Oct 19, 2017

Key People

Founding team and executive leadership

Yusuf Haque

Co Founder Chief Technical Officer

Founding Team

Alisha Johnson

Group CEO

Executive Team

Sandeep Akkaraju

CEO Founder

Founding Team

Exo Investors

Notable investors and investment history

InvestorRounds
Rising Tide FundSeries B Extension, Seed, Series B
Boldstart VenturesSeries B Extension, Series C
RA Capital ManagementSeries C
Sony Ventures CorporationSeed, Series B
Magnetar CapitalSeed, Series B, Series B Extension
Longevity Vision FundSeries B Extension, Series B, Series C, Seed
Creative VenturesSeries B Extension, Series C, Seed, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 19, 2026

    Sponsoring refreshment break at MEDTECH IMPACT SYMPOSIUM.

  • Jun 18, 2025

    New ultrasound AI cleared by FDA for detecting pleural effusion and consolidation/atelectasis.

Exo Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Exo Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Exo's valuation, stock price, and market status.

Firmographic Details

HeadquartersSanta Clara, California
Employee Range191
Year Founded2015
Last FundingMay 28, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.